175 related articles for article (PubMed ID: 28448783)
41. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
[TBL] [Abstract][Full Text] [Related]
42. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
43. Retrospective Review of Exceptions for Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Recommendations for a Diabetic Medicare Population.
Chinthammit C; Harrington A; Wild A; Werner S; Boesen K; Taylor AM; Warholak TL
J Manag Care Spec Pharm; 2019 Mar; 25(3):358-365. PubMed ID: 30816812
[TBL] [Abstract][Full Text] [Related]
44. Perceptions of the Value of Clinical Pharmacy Medication Review for Women During Early Pregnancy.
Lee M; Kurz D; Schwiesow S; Delate T; Campbell S; Rivera K; Olson K
J Manag Care Spec Pharm; 2020 Oct; 26(10):1301-1308. PubMed ID: 32996386
[TBL] [Abstract][Full Text] [Related]
45. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
46. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
Desai V; Nau D; Conklin M; Heaton PC
J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the Elderly.
Weddle SC; Rowe AS; Jeter JW; Renwick RC; Chamberlin SM; Franks AS
J Manag Care Spec Pharm; 2017 May; 23(5):520-524. PubMed ID: 28448781
[TBL] [Abstract][Full Text] [Related]
48. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
Peaslee A; Wickizer M; Olson J; Topp R
J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
[TBL] [Abstract][Full Text] [Related]
49. Developing a dashboard for benchmarking the productivity of a medication therapy management program.
Umbreit A; Holm E; Gander K; Davis K; Dittrich K; Jandl V; Odell L; Sweeten P
J Am Pharm Assoc (2003); 2017; 57(1):95-101.e1. PubMed ID: 27964887
[TBL] [Abstract][Full Text] [Related]
50. Potentially Harmful Medication Use Among Medicare Patients with Heart Failure.
Silva Almodóvar A; Nahata MC
Am J Cardiovasc Drugs; 2020 Dec; 20(6):603-610. PubMed ID: 32080822
[TBL] [Abstract][Full Text] [Related]
51. Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region.
Chinthammit C; Bhattacharjee S; Axon DR; Slack M; Bentley JP; Warholak TL; Wilson DL; Lo-Ciganic WH
J Manag Care Spec Pharm; 2020 Oct; 26(10):1309-1316. PubMed ID: 32996396
[TBL] [Abstract][Full Text] [Related]
52. Strategies for community-based medication management services in value-based health plans.
Smith MA; Spiggle S; McConnell B
Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
[TBL] [Abstract][Full Text] [Related]
53. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
Murugappan MN; Seifert RD; Farley JF
J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
[TBL] [Abstract][Full Text] [Related]
54. Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota.
Scott DM; Dewey MW; Johnson TA; Kessler ML; Friesner DL
Consult Pharm; 2010 May; 25(5):305-19. PubMed ID: 20497929
[TBL] [Abstract][Full Text] [Related]
55. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians.
Lauffenburger JC; Vu MB; Burkhart JI; Weinberger M; Roth MT
Am J Geriatr Pharmacother; 2012 Apr; 10(2):129-38. PubMed ID: 22284582
[TBL] [Abstract][Full Text] [Related]
56. Improving Medication Adherence in an ACO Primary Care Office With a Pharmacist-Led Clinic: A Report From the ACORN SEED.
Hale G; Moreau C; Joseph T; Phyu J; Merly N; Tadros N; Rodriguez MM
J Pharm Pract; 2021 Dec; 34(6):888-893. PubMed ID: 32578473
[TBL] [Abstract][Full Text] [Related]
57. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
Winston S; Lin YS
J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047
[TBL] [Abstract][Full Text] [Related]
58. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
[TBL] [Abstract][Full Text] [Related]
59. A new ballgame: comprehensive medication review.
McSpadden C
Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.
Tsang CCS; Wang J; Shih YT
Medicine (Baltimore); 2024 May; 103(18):e37935. PubMed ID: 38701304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
